Cancer Clinical Trial
Official title:
Does an Acute Bout of Exercise Affect Smoking Satisfaction?
Female and male smokers will complete questionnaires and smoking behavior will be examined.
After abstaining from smoking for approximately 18 hours, they will be randomized to a
moderate intensity exercise groups or passive sitting group. Smoking satisfaction and
smoking behavior will be assessed following treatment.
The hypotheses detailed below are specific to the randomization of participants into the
following 2 groups:
1. Moderate exercise (Experimental condition; MEG)
2. Passive sitting (Attention control condition; PSG)
Hypothesis 1: A bout of moderate intensity exercise will be associated with decreased
smoking satisfaction after a temporary period of abstinence compared to a control condition.
Hypothesis 2: Smoking topographic measures will mediate the relationship between a bout of
moderate intensity exercise and smoking satisfaction.
Lung cancer is the leading cause of cancer death in Canadians (Canadian Cancer Society
(CCS), 2010). Cigarette smoking is responsible for 85% of these cases (CCS, 2007). Exercise
has been shown to be an effective adjunct to pharmacological cessation strategies (Ussher,
Taylor, & Faulkner, 2008). A recent systematic review concluded that a single bout of low to
moderate intensity exercise can help regulate cravings, withdrawal symptoms and negative
affect associated with quitting (Taylor, Ussher, & Faulkner, 2007).
Smoking satisfaction is an immediately reinforcing effect of nicotine. Smoking satisfaction
may outweigh the temporally distant adverse health risks of smoking (Cappelleri, Bushmakin,
Baker, Merikle, Olufade, & Gilbert, 2007). Varenicline, an alpha 4-beta-2 nAChR partial
agonist, mimics the effect of nicotine by reducing cravings and withdrawal symptoms (Coe et
al., 2005). A 12-week treatment period of varenicline has been shown to reduce smoking
satisfaction (Jorenby et al., 2006). However, the effect of acute exercise on smoking
satisfaction is not yet known.
Smoking topography is a key facet of smoking behaviour. Smoking behaviour can be
subjectively or objectively measured by quantifying puff volume, maximum puff velocity,
inter-puff interval, puff duration, number of puffs per cigarette and time to smoke a single
cigarette. Smoking topography can estimate exposure to carcinogenic toxins present in
cigarette smoking (Djordjevic, Hoffman, & Hoffman, 1997). Evidence exists to support that
exercise modifies smoking topography (Katomeri & Taylor 2006; Mikhail, 1983; Reeser, 1983;
Zacny & Stitzer, 1985).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|